This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Okabe, M. Articles by Kikuchi, M. Search for Related Content PubMed PubMed Citation Articles by Okabe, M. Articles by Kikuchi, M. Pubmed/NCBI databases Medline Plus Health Information Cardiomyopathy Hepatitis C

(Circulation. 1997;96:22-24.)
© 1997 American Heart Association, Inc.

Articles

Chronic Variant of Myocarditis Associated With Hepatitis C Virus Infection

Masanori Okabe, MD; Keisuke Fukuda, MD; Kikuo Arakawa, MD; ; Masahiro Kikuchi, MD

From the Departments of Internal Medicine (M.O., K.F., K.A.) and Pathology (M.K.), School of Medicine, Fukuoka University, Japan.

Correspondence to Masanori Okabe, MD, Second Department of Internal Medicine, School of Medicine, Fukuoka University, 7-45-1, Nanakuma, Jonan-ku, Fukuoka 814-80, Japan.

Background Although molecular biological studies suggest a pathogenic link between enterovirus infection and dilated cardiomyopathy (DCM), the frequency of detection of enteroviral RNA is not consistently high in myocardial tissue from patients with DCM. A recent study has suggested that hepatitis C virus (HCV) may also be involved in the development of DCM.

Methods and Results We performed genomic analysis for HCV in three patients with chronic active myocarditis. In all three patients, serum aminotransferase activities remained within normal ranges until the terminal stage of heart failure. At necropsy, all three livers showed evidence of tissue damage caused by chronic congestion, and one liver had evidence of chronic hepatitis. Routinely processed, paraffin-embedded tissue blocks of myocardium and liver were analyzed. Renal specimens were also analyzed to exclude the possibility of myocardial contamination with HCV material from the circulating blood. RNA extracted from the heart, liver, and kidney was subjected to strand-specific reverse transcription and amplified by semi-nested polymerase chain reaction. The target nucleotide sequence was a 178-bp fragment of the highly conserved 5'-noncoding region. Both positive- (genomic) and negative-strand RNA (replicative intermediates) were present in myocardial and liver tissue samples from all three patients. However, negative-strand RNA was undetectable in renal tissue from one patient.

Conclusions These findings suggest that HCV replicated in myocardial tissue of these patients with myocarditis. Thus, HCV infection may contribute to the development of this unusual form of myocarditis.

Key Words: myocarditis • heart failure • polymerase chain reaction • viruses

This article has been cited by other articles:

				J. W. Magnani and G. W. Dec Myocarditis: Current Trends in Diagnosis and Treatment Circulation, February 14, 2006; 113(6): 876 - 890. [Full Text] [PDF]

				A. Matsumori Hepatitis C Virus Infection and Cardiomyopathies Circ. Res., February 4, 2005; 96(2): 144 - 147. [Full Text] [PDF]

				F. Calabrese and G. Thiene Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects Cardiovasc Res, October 15, 2003; 60(1): 11 - 25. [Abstract] [Full Text] [PDF]

				F.-J. Authier, G. Bassez, C. Payan, L. Guillevin, J.-M. Pawlotsky, J.-D. Degos, R. K. Gherardi, and L. Belec Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy Neurology, March 11, 2003; 60(5): 808 - 812. [Abstract] [Full Text] [PDF]

				A. Frustaci, C. Chimenti, F. Calabrese, M. Pieroni, G. Thiene, and A. Maseri Immunosuppressive Therapy for Active Lymphocytic Myocarditis: Virological and Immunologic Profile of Responders Versus Nonresponders Circulation, February 18, 2003; 107(6): 857 - 863. [Abstract] [Full Text] [PDF]

				K. Klingel, H.-C. Selinka, M. Sauter, C.-T. Bock, G. Szalay, and R. Kandolf Molecular mechanisms in enterovirus and parvovirus B19 associated myocarditis and inflammatory cardiomyopathy Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I8 - I12. [Abstract] [PDF]

				A. Frustaci, F. Calabrese, C. Chimenti, M. Pieroni, G. Thiene, and A. Maseri Lone Hepatitis C Virus Myocarditis Responsive to Immunosuppressive Therapy Chest, October 1, 2002; 122(4): 1348 - 1356. [Abstract] [Full Text] [PDF]

				C. Chimenti, F. Calabrese, G. Thiene, M. Pieroni, A. Maseri, and A. Frustaci Inflammatory Left Ventricular Microaneurysms as a Cause of Apparently Idiopathic Ventricular Tachyarrhythmias Circulation, July 10, 2001; 104(2): 168 - 173. [Abstract] [Full Text] [PDF]

				A. M. Feldman and D. McNamara Myocarditis N. Engl. J. Med., November 9, 2000; 343(19): 1388 - 1398. [Full Text] [PDF]

				C. Kawai From Myocarditis to Cardiomyopathy: Mechanisms of Inflammation and Cell Death : Learning From the Past for the Future Circulation, March 2, 1999; 99(8): 1091 - 1100. [Abstract] [Full Text] [PDF]

				J.-H. Kao, J.-J. Hwang, M. Okabe, K. Fukuda, K. Arakawa, and M. Kikuchi Hepatitis C Virus Infection and Chronic Active Myocarditis • Response Circulation, September 8, 1998; 98(10): 1044 - 1045. [Full Text]

				S. Navas, J. Martin, J. A. Quiroga, I. Castillo, and V. Carreno Genetic Diversity and Tissue Compartmentalization of the Hepatitis C Virus Genome in Blood Mononuclear Cells, Liver, and Serum from Chronic Hepatitis C Patients J. Virol., February 1, 1998; 72(2): 1640 - 1646. [Abstract] [Full Text] [PDF]